UiPath (PATH) shares extended their decline on Wednesday, falling 1.49% in pre-market trading to $10.59, following a 3.76% drop in the regular session to $10.75. The selloff came as investors continued to question the company's growth trajectory, particularly the pace of annual recurring revenue (ARR) expansion relative to headline revenue.
The company reported fiscal first-quarter revenue of $418 million, up 17% year-over-year, which exceeded expectations. However, ARR grew only 12% to $1.901 billion, a metric that has become a point of contention. The divergence between revenue and ARR growth has led some to label PATH a 'show me' stock, as doubts linger about the sustainability of its AI automation-driven business model.
Investors are now laser-focused on the company's second-quarter ARR guidance, which ranges from $1.929 billion to $1.934 billion. The midpoint of this forecast implies net new ARR of approximately $30.5 million, a sharp deceleration from the $49 million added in Q1. This slowdown has amplified concerns that the adoption of AI automation is not translating into faster recurring revenue growth.
The broader market selloff added to the pressure, with the Nasdaq Composite falling 0.97% on Tuesday. The S&P 500 technology index declined 1.8%, while the Philadelphia Semiconductor Index dropped 1.9%. Market analysts characterized the moves as part of a 'momentum unwind' in tech stocks.
Despite the stock's weakness, UiPath reported several positive financial metrics. The company achieved GAAP operating income of $28 million for the quarter, its first quarter of GAAP profitability. Non-GAAP operating income reached $92 million, and operating cash flow was $132 million. The balance sheet remains strong, with $1.416 billion in cash, cash equivalents, and marketable securities as of April 30.
Management has been touting the shift from pilot programs to production deployments of its agentic AI products, which combine AI agents, automation bots, and human workers. CEO Daniel Dines highlighted this transition in the earnings release, while COO and CFO Ashim Gupta emphasized the milestone of GAAP profitability.
Analyst sentiment remains cautious but not bearish. According to Google Finance, 17 analysts covering PATH over the past three months have a consensus Hold rating, with 2 Buys, 14 Holds, and 1 Sell. The average 12-month price target is $13.31, offering limited upside from current levels.
The company's $500 million share buyback program, approved in March, is underway. UiPath repurchased 20.4 million shares in the last quarter at an average price of $11.47, and an additional 2.4 million shares from May 1 to May 15 at an average of $9.63. While buybacks can support per-share metrics, growth-oriented investors are seeking more concrete evidence of AI-driven demand acceleration.
Looking ahead, the key catalyst for PATH remains the Q2 ARR target. The company's ability to hit that range will be critical in determining whether enterprise AI automation is gaining real momentum or if the current slowdown in recurring revenue growth is a more structural issue. With tech spending still uncertain and competition intensifying, UiPath faces a challenging path to convince the market that its AI orchestration platform can deliver sustained growth.
